1.
Schläpfer A, Auclair C, Janji B, Karam M, Zaeem Noman M. The ’Holy Grail’ in Immuno-Oncology: AC BioScience SA is Aiming to Potentiate Anti-PD-1 Therapy Efficacy through Tumor Cell Conditioning Strategy. Chimia [Internet]. 2020 Oct. 28 [cited 2024 Apr. 20];74(10):771. Available from: https://www.chimia.ch/chimia/article/view/2020_771